Teva to Present at the UBS Global Life Sciences Conference

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Life Sciences Conference with William Marth, President and Chief Executive Officer, Teva North America presenting on Wednesday, September 23, 2009, in New York.

What:    Teva Presentation at the UBS Global Life Sciences Conference
Who:     William Marth, President and Chief Executive Officer, Teva North
         America
When:    Wednesday, September 23, 2009 at 10:00 a.m. ET
Where:   http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=28_86B3RLL
         or http://www.tevapharm.com/financial/
How:     Live over the Internet -- log on to the Web at the address above and
         register for the event (approx. 10 minutes before). An archive of
         the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.

SOURCE: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. 
Elana Holzman, 972 (3) 926-7554 
or 
Teva North America 
Kevin Mannix, 215-591-8912

Related terms: animal, ceo, conference, europe, health, israel, manufacturer, nasdaq, new york, north america, pharmaceuticals, president, products, sales